Fritextsökning
Innehållstyper
-
Tirzepatide approved for obesity by the FDA – to be branded as Zepbound
Diabetes drug tirzepatide has now also been approved in the US for treating obesity.
-
The Swedish Life Science Office: “We lost in both coordination and manpower”
Since the turn of the year, the Swedish government’s life science office has operated at a lower capacity. Life Science Sweden has spoken to Pontus Holm, Depart...
-
Improve your secondary battery manufacturing
SMC provides a large portfolio of products specially designed for secondary battery industry.
-
Neogap vinner pris – satsar på internationell utveckling
Bioteknikföretaget Neogap har utsetts till vinnare av ett scale up-program som genomförs av Buisness Sweden.
-
The Swedish innovation model: “There is a paradox”
It is often said that Sweden is strong when it comes to innovation, but how well are we turning that innovation into actual medicines?
-
Automated dispensing of liquids
Have a look at how you can do easier and faster dispensing on the fly adapted to your needs
-
Novo Nordisk to invest billions in Danish manufacturing facilities
Danish pharmaceutical giant Novo Nordisk is investing DKK 42 billion, equivalent to around SEK 65 billion/EUR 5.6 billion, in its manufacturing facilities in Ka...
-
Mathias Uhlén’s protein atlas is recognised as a global resource
The Human Protein Atlas is the first database in Sweden to be designated a Global Core Biodata Resource. According to Mathias Uhlén, this is a quality hallmark ...
-
Heidi Stensmyren is eager for new challenges in the biotech industry
Heidi Stensmyren has served as President of the Swedish Medical Association, held a managerial position at Karolinska University Hospital and is now Medical Dir...
-
Misstänkt koppling mellan Ozempic och ögonsjukdom – myndighet reagerar
Två nya danska studier har pekat på en koppling mellan Ozempic (semaglutid) och en möjlig risk för den sällsynta ögonsjukdomen NAION. Nu vill danska läkemedelsv...
-
Anna Törner: The clinical trial – Periscope to reality
What happens to the patients in the clinical trial is not very interesting, writes Anna Törner in a column.
-
Meet the governmental life science office
More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duti...
-
The first drugs to slow down Alzheimer’s – but what does it mean for patients?
New treatments for early Alzheimer’s are bringing hope to thousands of patients and their families. The question is, who will get the treatment, how will the ri...
-
Webinar: How to Plan And Analyze a Real-World Evidence Study
This webinar is for drug developers who want to understand the basic ideas of analyzing an RWE study, as well as avoiding the most common pitfalls.
-
Nässprej för behandling av anafylaxi godkänd i USA
Den amerikanska läkemedelsmyndigheten, FDA, har gett tummen upp till en ny typ av nässprej. Nässprejen är ett injektionsfritt alternativ för behandling av akuta...
-
“Together Stockholm-Uppsala and Medicon Valley can make Scandinavia a leading life science region”
“Denmark, Sweden, Norway and Finland all have national life science strategies, but the Swedish strategy is the only one explicitly emphasizing the Nordic dimen...
-
Ännu ett genterapibolag krisar – säger upp 100
Det är tuffa tider för många cell- och genterapibolag. Det senaste exemplet är amerikanska Bluebird Bio, som säger upp var fjärde anställd i ett försök att rädda verksamheten.
-
Svenska medtechföretag klara för stor Ukraina-mässa
Elekta, Medicover och Arjo. Det är några av de företag som deltar i den svenska paviljongen på Rebuild Ukraine: Health & Rehabilitation i Warszawa i sommar.
-
Bicos vd i blåsväder – uppgav fel utbildning
Det blåser kring medtechbolaget Bico. Förra veckan meddelade finanschefen Gusten Danielsson att han avgår med omedelbar verkan och på stämman röstade han mot at...
-
Samuel Lagercrantz: The government’s performance in healthcare and life sciences so far
Since the change of government in Sweden, developments in the healthcare sector have shown promising signs, but the outlook in life sciences is less promising, ...
-
Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation
A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure t...
-
EU Pharmaceutical Legislation Reform
The EU's Pharmaceutical Legislation Reform, proposed by the commission within the European Health Union, aims to establish a citizen-centric framework to enhanc...
-
Bilden av Alzheimers – neurobiolog vid SU och KI får Lennart Nilssons pris
Med fascinerande bilder och filmer i 3D har han bidragit till ökad kunskap om allt från innerörats anatomi till sjukdomar som fettlever och Alzheimers. Nu tilld...
-
Life Science Sweden heads to the Oresund region! ‒ Hello there Michael Linnell
Life Science Sweden’s The Future of Swedish Danish Life Science and New Updates in Drug Formulation & Bioavailability meetings are coming up soon. We asked Mich...
BREAKING